Entity
  • Poolbeg Pharma plc

    Created in 2021
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    3,054
  • Activities

  • Technologies

  • Entity types

  • Location

    Floor 24, 40 Bank St, London E14 5NR, UK

    London

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 15

  • Engaged corporates

    7
    0 7
  • Added in Motherbase

    1 year, 8 months ago
Description
  • Value proposition

    Focused on the development & commercialisation of innovative medicines.

    Ticker: POLB

    Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.

    Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members of the Amryt Pharma plc leadership team, with the intention of repeating Amryt’s success and generating near term revenues.

    Poolbeg’s clinical programmes target large addressable markets including cancer immunotherapy-induced Cytokine Release Syndrome (CRS) and metabolic conditions such as obesity with the development of an oral GLP-1R agonist. It uses a cost-effective development philosophy to generate high quality data to support partnering and further development. Its AI-led discovery programmes analyse unique data from human challenge trials to identify clinically relevant drug targets and treatments, leading to faster development and greater commercial appeal.

    cancer immunotherapy, oncology, GLP-1 agonist, obesity, RSV, influenza, oral vaccines, Oral GLP-1, metabolic conditions, Artificial Intelligence, and AI

  • Poolbeg Pharma - A Leading Biopharmaceutical Company

    Poolbeg Pharma is focussed on acquiring, developing & commercialising innovative medicines targeting diseases with a high unmet medical need

  • https://www.poolbegpharma.com/
Corporate interactions BETA
Corporate TypeTweets Articles
PharmaTimes Media Ltd
PharmaTimes Media Ltd
Pharmaceutical, Pharmaceutical Manufacturing
PharmaTimes Media Ltd
Pharmaceutical, Pharmaceutical Manufacturing
Other

11 Dec 2024


KPMG
KPMG
Consulting, audit, Accounting
KPMG
Consulting, audit, Accounting
Other

24 Oct 2024


Dia & Co
Dia & Co
Semiconductors, Retail Apparel and Fashion
Dia & Co
Semiconductors, Retail Apparel and Fashion
Other

29 Jul 2024


Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Other

29 Jul 2024


Biotechnology Innovation Organization Biotechnology Innovation Organization
Other

10 Jun 2024


Financial Times
Financial Times
Media, Newspaper Publishing
Financial Times
Media, Newspaper Publishing
Other

17 Oct 2024


Tiroler Tageszeitung
Tiroler Tageszeitung
Hospitality, Media Production
Tiroler Tageszeitung
Hospitality, Media Production
Other

19 Oct 2023


Similar entities
Loading...
Loading...
Social network dynamics